Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
A multi-center, randomized, double-blind, placebo-controlled, 4-arm clinical study to
evaluate efficacy and safety of nicotine lozenge (2mg and 4mg) in smoking cessation in adult
cigarette smokers who are motivated to quit smoking. Successful quitters or participants who
smoke occasionally will be followed up after week 24 till 12 months.